Related Experiment Videos
Elevated fracture risk in a Danish cohort with type 2 diabetes mellitus and microvascular diseases
Mohamad I Nasser1,2,3, Therese K Grønborg4,5, Frederik P B Kristensen4,5
1Department of Endocrinology and Metabolism, Molecular Endocrinology Laboratory (KMEB), Odense University Hospital, Odense, 5230, Denmark.
Introduction:
Microvascular diseases (MVD) in type 2 diabetes mellitus (T2D) are associated with alterations in the bone microarchitecture, but their association with fracture risk is unclear. We investigated whether MVD (retinopathy, nephropathy, and neuropathy) are associated with higher fracture risk in persons with T2D.
Materials And Methods:
We identified 10 491 persons with T2D, enrolled in the Danish Centre for Strategic Research in Type 2 Diabetes cohort between 2010 and 2022. The primary outcomes were any hospital-diagnosed fracture (except facial and cranial), and major osteoporotic fractures (MOF), defined as clinical vertebral, hip, humerus, and forearm fractures, in persons with hospital-diagnosed MVD vs without MVD. We used Cox proportional hazard models to calculate crude and adjusted hazard ratios (aHRs).
Results:
During a median follow-up of 7.6 yr IQR (3.5; 9.7), the rates of any fracture were higher in persons with T2D and MVD vs no MVD (aHR 1.31; 95% CI [1.15; 1.51]). Similarly, MOF rate was elevated in persons with MVD (aHR 1.33 [1.09; 161]). The rates for any fracture and MOF were highest in persons with neuropathy (aHR 1.49 [1.24; 1.78] and aHR 1.54 [1.19; 1.99], respectively).
Discussion:
Fracture risk is elevated in persons with T2D complicated by MVD, particularly in those with neuropathy.
Insights
Microvascular diseases (MVD) in type 2 diabetes mellitus (T2D) increase fracture risk. Neuropathy, a type of MVD, showed the highest fracture risk in T2D patients.
Area of Science:
- Endocrinology
- Diabetology
- Bone Health
Background:
- Microvascular diseases (MVD) in type 2 diabetes mellitus (T2D) are linked to bone microarchitecture changes.
- The association between MVD and fracture risk in T2D patients remains unclear.
Purpose of the Study:
- To investigate if MVD, including retinopathy, nephropathy, and neuropathy, is associated with an increased risk of fractures in individuals with T2D.
Main Methods:
- A cohort of 10,491 individuals with T2D was analyzed between 2010 and 2022.
- Fracture outcomes (any fracture and major osteoporotic fractures) were compared between individuals with and without hospital-diagnosed MVD.
- Cox proportional hazard models were used to calculate hazard ratios.
Main Results:
- Individuals with T2D and MVD had a higher rate of any fracture (aHR 1.31) and major osteoporotic fractures (aHR 1.33) compared to those without MVD.
- Neuropathy was associated with the highest risk for both any fracture (aHR 1.49) and major osteoporotic fractures (aHR 1.54).
Conclusions:
- Fracture risk is elevated in individuals with type 2 diabetes mellitus complicated by microvascular diseases.
- Neuropathy is a significant risk factor for fractures in this patient population.
Related Concept Videos
Diabetic Retinopathy
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Psychoneuroimmunology: Diabetes and Cancer